AI governance for healthcare, where data sensitivity is highest
Clinical teams are adopting AI faster than governance programs can keep up. PHI is entering tools without BAAs. Departments are making independent decisions about AI vendors. Clarier gives you visibility, control, and the compliance evidence your privacy office needs.
Healthcare AI adoption creates unique governance gaps
The combination of highly sensitive data, distributed clinical teams, and evolving regulations makes healthcare AI governance fundamentally different from other industries.
Clinical Staff Adopting AI Without IT Knowledge
Physicians are using AI tools to draft clinical notes, summarize patient histories, and support diagnostic reasoning. Nurses are using AI for patient communication templates. Researchers are running data through LLMs for literature review. In most cases, IT and security have no visibility into which tools are being used or what data is being entered.
HIPAA Applies to AI Too
Every time protected health information is entered into an AI tool, that creates a potential HIPAA violation unless a Business Associate Agreement is in place. Most consumer AI tools do not offer BAAs. Even those that do may retain data, process it across borders, or use it for model training. The compliance surface area is larger than most privacy officers realize.
Administrative AI Sprawl Across Departments
Revenue cycle teams are using AI for coding optimization. Scheduling departments are testing AI-powered patient engagement tools. Marketing is using generative AI for content. Each department is adopting independently, creating a fragmented landscape where no single person knows the full picture of AI usage across the organization.
State-Level Regulations Adding Complexity
Beyond HIPAA, state-level AI regulations are emerging rapidly. Some states require disclosure when AI is used in clinical decision-making. Others mandate patient consent before AI processes their data. Washington, Colorado, and California have already enacted AI-specific provisions. Your governance program needs to account for where your patients are, not just where your systems are.
Governance that respects the pace of care delivery
Clarier maps directly to the compliance requirements healthcare organizations face, without adding friction to clinical workflows.
Shadow AI Discovery
Addresses: Clinical Shadow AIFind AI tools in use across clinical, administrative, research, and support departments. Clarier integrates with your identity provider, network gateway, endpoint tools, and DLP systems to surface AI adoption you cannot see from IT alone. Know what is being used before PHI is exposed.
HIPAA-Focused Vendor Research
Addresses: HIPAA ComplianceEvery AI vendor research report evaluates BAA availability, PHI handling practices, data retention policies, encryption standards, and subprocessor chains. Trust ratings from A to F give your privacy and compliance teams a clear, comparable assessment so decisions are based on evidence, not vendor marketing.
Department Attribution
Addresses: Admin SprawlSee which departments and roles are using which AI tools and at what volume. Understand whether clinical teams, billing, HR, or research are driving adoption. This visibility lets you prioritize governance efforts where the data sensitivity is highest.
Approval Workflows with HIPAA Review
Addresses: PHI ProtectionBuild approval workflows that require privacy and compliance review before any tool can be used with PHI. Route requests to the right reviewers based on data sensitivity, department, and use case. Ensure that BAA status is verified before a tool is approved for clinical or administrative use.
Audit Trail for OCR Investigations
Addresses: Regulatory ReadinessEvery evaluation, approval, denial, and policy change is recorded with full context. If the Office for Civil Rights opens an investigation, you have a complete, timestamped record of your AI governance decisions, not a scramble to reconstruct what happened from email threads and meeting notes.
The PHI protection gap, visualized
What changes when you move from ad-hoc AI management to a structured governance program.
Without governance
- PHI entering AI tools without BAAs in place
- No visibility into clinical AI adoption across departments
- Vendor assessments that miss AI-specific HIPAA risks
- OCR investigations met with scrambled reconstruction
- State-level AI requirements tracked in spreadsheets
With Clarier
- BAA status verified before any tool touches PHI
- Full inventory of AI tools across clinical and admin teams
- HIPAA-focused vendor research with trust ratings A through F
- Complete, timestamped audit trail for OCR readiness
- Multi-state compliance tracked in a single platform
Governance without slowing down care
Healthcare organizations use Clarier to close the gap between AI adoption and compliance.
Sources & further reading
Primary sources and official references cited on this page.
Protect PHI while enabling clinical AI innovation.
See how Clarier helps healthcare organizations govern AI across clinical, administrative, and research teams.